Nesta página
IMDX Insight Molecular Diagnostics Inc. - Common Stock
NASDAQ · Biotechnology · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Ago 10, 2026
$3,44
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$2,42mínima 52 sem
$8,51máxima 52 sem
Capitalização de Mercado (MRQ)
$112M
P/E (TTM)
-2.3
EPS (TTM)
$-1.52
Receita (TTM)
$2M
seus distintivos
Intervalo 52 Semanas
$2–$9
Classificação do Analista
BUY
Preço-Alvo
$8
P/E
-2.3
ROE
488.7%
Margem de Lucro Líquido
-2955.6%
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
IMDX Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$3.44
Capitalização de Mercado (MRQ)
$112M
P/E (TTM)
-2.3
EPS (TTM)
$-1.52
Receita (TTM)
$2M
ROE (TTM)
488.7%
Intervalo 52 Semanas
$2–$9
IMDX Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Divisões de Ações
| Data ex | Desdobramento | Tipo |
|---|---|---|
| 25 de Julho de 2023 | 1-for-20 | Reverso |
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$4M2020-12-31 → 2025-12-31
EPS$-1.652022-12-31 → 2025-12-31
Fluxo de caixa livre$-25M2016-12-31 → 2025-12-31
Margem líquida-2955.6%2016-12-31 → 2025-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | IMDX | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | -2.3média 5A ≈-1.6 | ≈-1.6 | · | · | |
| P/S (TTM) | 67.2média 5A ≈29.6 | ≈29.6 | 43.3 | Sobreavaliado | |
| P/B (MRQ) | -5.3média 5A ≈-3.1 | ≈-3.1 | · | · | |
| Preço / FCF (TTM) | -3.6média 5A ≈-3.8 | ≈-3.8 | · | · | |
| Preço / Fluxo de Caixa (TTM) | -4.2média 5A ≈-4.2 | ≈-4.2 | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | IMDX | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Bruta (TTM) | 47.6%média 5A ≈41.2% | ≈41.2% | · | · | |
| Margem Operacional (TTM) | -3011.9%média 5A ≈-2059.4% | ≈-2059.4% | -583.5% | Fraco | |
| Margem EBITDA (TTM) | -2865.6%média 5A ≈-2013.7% | ≈-2013.7% | -583.5% | Fraco | |
| Margem de Lucro Líquido (TTM) | -2955.6%média 5A ≈-2104.0% | ≈-2104.0% | -597.4% | Fraco | |
| ROA (TTM) | -123.5%média 5A ≈-102.4% | ≈-102.4% | -54.3% | Fraco | |
| ROE (TTM) | 488.7%média 5A ≈1655.5% | ≈1655.5% | -61.8% | Primeira linha |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | IMDX | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Índice de liquidez corrente (MRQ) | 2.0média 5A ≈1.5 | ≈1.5 | 7.7 | Baixa liquidez | |
| Quick Ratio (Índice de Liquidez Seca) | 1.1média 5A ≈1.3 | ≈1.3 | 7.5 | Baixa liquidez |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | IMDX | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | 115.6%média 5A ≈44.4% | ≈44.4% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | 61.8%média 5A ≈21.3% | ≈21.3% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 27.2% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | IMDX | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 0.1média 5A ≈0.1 | ≈0.1 | 0.1 | Primeira linha | |
| Inventory Turnover (Giro de Estoque) | 4.1 | · | · | · | |
| Receivables Turnover (Giro de Contas a Receber) | 3.0média 5A ≈2.5 | ≈2.5 | · | · | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$73.7K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-86.3%
Próximo relatório
Nov 09, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Ago 10, 2026 | $-0.31 | $-0.25 | -24.4% |
| 31 de Março de 2026 | Mai 13, 2026 | $-0.12 | $-0.27 | 55.0% |
| 31 de Dezembro de 2025 | $-0.72 | $-0.24 | -197.5% | |
| 30 de Setembro de 2025 | $-0.34 | $-0.21 | -59.0% | |
| 30 de Junho de 2025 | $-0.30 | $-0.23 | -27.9% | |
| 31 de Março de 2025 | $-0.26 | $-0.24 | -7.8% | |
| 31 de Dezembro de 2024 | $-1.93 | $-0.44 | -342.8% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $2M | $2M | $958.0K | $2M | $1M | · | · | · | · | $0 | |
| Cost of Revenue | $2M | $1M | $1M | $880.0K | $697.0K | $2M | · | · | · | · | · | |
| Gross Profit | $2M | $740.0K | $413.0K | $-18.0K | $1M | $-639.0K | · | · | · | · | · | |
| R&D Expense | $16M | $10M | $9M | $7M | $5M | $10M | $7M | $7M | $7M | $6M | $5M | |
| SG&A Expense | $11M | $10M | $11M | $22M | $22M | $17M | $13M | $7M | $9M | $4M | $4M | |
| Operating Expenses | $53M | $62M | $26M | $18M | $55M | $29M | $22M | $15M | $19M | $11M | $9M | |
| Operating Income | $-51M | $-61M | $-25M | $-18M | $-54M | $-30M | $-22M | $-15M | $-19M | $-11M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $0 | $18.0K | |
| Other Non-op | $1M | $462.0K | $394.0K | $-61.0K | $-37.0K | $27.0K | $-3.0K | $91.0K | $-309.0K | $0 | $2.0K | |
| Pretax Income | · | $-61M | $-25M | $-19M | $-53M | $-31M | $-22M | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | · | $-9M | $-1M | · | · | · | · | · | |
| Net Income | $-50M | $-61M | $-28M | $-73M | $-64M | $-30M | $-22M | $-16M | $-19M | $-11M | $-9M | |
| EPS (Basic) | $-1.65 | $-4.66 | $-3.75 | $-13.25 | $-0.72 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.65 | $-4.66 | $-3.75 | $-13.25 | · | · | · | · | · | · | · | |
| Shares (Basic) | 30,476,000 | 13,071,000 | 7,651,000 | 5,540,000 | 88,920 | · | · | · | · | · | · | |
| Shares (Diluted) | 30,476,000 | 13,071,000 | 7,651,000 | 5,540,000 | · | · | · | · | · | · | · | |
| EBITDA | $-49M | $-59M | $-25M | · | · | · | · | · | · | $-11M | · |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $9M | $9M | $20M | $33M | $7M | $22M | $8M | $8M | $10M | $8M | |
| Receivables | $1M | $2M | $484.0K | $2M | $1M | $203.0K | · | · | · | · | · | |
| Inventory | $446.0K | $410.0K | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $821.0K | $643.0K | $977.0K | $901.0K | $1M | $505.0K | $180.0K | $168.0K | $285.0K | $388.0K | |
| Other Current Assets | · | · | · | · | $85.0K | $295.0K | $36.0K | $78.0K | · | $103.0K | $22.0K | |
| Current Assets | $15M | $12M | $11M | $26M | $39M | $9M | $23M | $9M | $9M | $13M | $11M | |
| PP&E (Net) | $6M | $6M | $5M | $9M | $7M | $4M | $4M | $614.0K | $822.0K | $688.0K | $576.0K | |
| PP&E (Gross) | · | · | · | · | $7M | $2M | $1M | $2M | $1M | $1M | $750.0K | |
| Accum. Depreciation | $7M | $8M | $6M | $4M | $3M | $1M | $343.0K | $948.0K | $657.0K | $319.0K | $174.0K | |
| Goodwill | · | · | · | · | $19M | $9M | · | · | · | · | · | |
| Intangibles | $0 | $15M | $57M | $62M | $62M | $15M | · | · | $746.0K | $988.0K | $1M | |
| Other Non-current Assets | $593.0K | $691.0K | $463.0K | $371.0K | $264.0K | $356.0K | $93.0K | · | · | · | · | |
| Total Assets | $26M | $35M | $75M | $100M | $160M | $55M | $40M | $10M | $10M | $14M | $13M | |
| Accounts Payable | $3M | $2M | $953.0K | $1M | $2M | $432.0K | $469.0K | $166.0K | $175.0K | $422.0K | $285.0K | |
| Accrued Liabilities | $2M | $2M | $2M | $2M | $3M | $3M | · | · | $636.0K | $549.0K | $325.0K | |
| Current Liabilities | $12M | $7M | $7M | $12M | $14M | $9M | $4M | $6M | $4M | $4M | $2M | |
| Capital Leases | · | · | · | · | · | · | · | $187.0K | $289.0K | $310.0K | $0 | |
| Total Liabilities | $57M | $47M | $49M | $60M | $94M | $22M | $9M | $6M | $6M | $5M | $2M | |
| Long-term Debt | · | · | · | · | · | · | · | · | $2M | · | · | |
| Common Stock | $369M | $338M | $310M | $295M | $253M | $157M | $125M | $75M | $60M | $46M | $35M | |
| Retained Earnings | $-401M | $-351M | $-290M | $-261M | $-188M | $-124M | $-94M | $-71M | $-55M | $-35M | $-24M | |
| AOCI | $86.0K | $21.0K | $49.0K | $39.0K | $37.0K | · | · | · | $-888.0K | $-654.0K | $-350.0K | |
| Stockholders' Equity | $-31M | $-12M | $20M | $34M | $65M | $33M | $31M | $3M | $4M | $10M | $10M | |
| Liabilities + Equity | $26M | $35M | $75M | $100M | $160M | $55M | $40M | $10M | $10M | $14M | $13M | |
| Shares Outstanding | 28,683,000 | 17,453,000 | 8,261,000 | 5,932,000 | 92,232,000 | 69,117,000 | 57,032,000 | 40,664,000 | 31,452,000 | 28,737,000 | 25,391,000 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $800.0K | $313.0K | · | · | · | · | · | |
| Stock-based Comp | $2M | $2M | $3M | $10M | $7M | $5M | $3M | $1M | $2M | · | · | |
| Deferred Tax | · | · | $0 | $0 | $-9M | $-1M | · | · | · | · | · | |
| Amort. of Intangibles | $7.0K | $88.0K | $88.0K | $4M | $3M | $81.0K | · | $121.0K | $242.0K | $242.0K | $242.0K | |
| Other Non-cash | $24M | $37M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-22M | $-21M | $-23M | $-46M | $-36M | $-26M | $-20M | $-12M | $-13M | $-8M | $-4M | |
| CapEx | $3M | $516.0K | $281.0K | $4M | $2M | $1M | $918.0K | $31.0K | $91.0K | $106.0K | $500.0K | |
| Investing Cash Flow | $-3M | $-512.0K | $-932.0K | $-4M | $-14M | $-12M | $-12M | $-31.0K | $843.0K | $-181.0K | $315.0K | |
| Debt Issued | · | · | · | · | · | $1M | · | · | · | · | · | |
| Stock Issued | $29M | $26M | $14M | $33M | $65M | $18M | $49M | $10M | · | $0 | $12M | |
| Net Stock Activity | $29M | $26M | $14M | · | · | · | · | · | · | $0 | · | |
| Financing Cash Flow | $28M | $20M | $12M | $36M | $78M | $23M | $48M | $12M | $10M | $10M | $12M | |
| Net Change in Cash | $3M | $-796.0K | $-12M | $-14M | $28M | $-15M | $16M | $434.0K | $-3M | $2M | $8M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-25M | $-21M | $-24M | · | · | · | · | · | · | $-8M | · |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 56.7% | 39.3% | 27.5% | · | · | · | · | · | · | · | · | |
| Operating Margin | -1260.8% | -3245.1% | -1672.4% | · | · | · | · | · | · | 39785.7% | · | |
| Net Margin | -1238.5% | -3225.0% | -1848.4% | · | · | · | · | · | · | 39885.7% | · | |
| Pretax Margin | · | -3225.0% | -1653.7% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1206.6% | -3162.0% | -1672.4% | · | · | · | · | · | · | 39785.7% | · | |
| ROA | -165.1% | -110.3% | -31.8% | · | · | · | · | · | · | -82.2% | · | |
| ROE | 330.8% | 4733.8% | -98.2% | · | · | · | · | · | · | -110.1% | · | |
| ROIC | · | 497.3% | · | · | · | · | · | · | · | · | · |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.6 | 1.5 | · | · | · | · | · | · | 3.0 | · | |
| Quick Ratio | 1.1 | 1.4 | 1.4 | · | · | · | · | · | · | 2.4 | · |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | · | · | · | · | · | · | -0.0 | · | |
| Inventory Turnover | 4.1 | 5.1 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 3.0 | 1.8 | 2.8 | · | · | · | · | · | · | · | · |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-1.10 | $-0.70 | $2.48 | · | · | · | · | · | · | $0.34 | · | |
| Revenue / Share | $0.13 | $0.14 | $0.20 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.73 | $-1.58 | $-3.05 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.40 | $0.49 | $1.14 | · | · | · | · | · | · | $0.35 | · | |
| EPS (TTM) | $-1.65 | $-4.66 | $-3.75 | $-13.25 | · | · | · | · | · | · | · |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 115.6% | 25.1% | 56.9% | -56.4% | 80.8% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 61.8% | -5.1% | 7.3% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 27.2% | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $2M | $2M | $958.0K | $2M | $1M | · | · | · | · | $0 | |
| Net Income TTM | $-50M | $-61M | $-28M | $-73M | $-64M | $-30M | $-22M | $-16M | $-19M | $-11M | $-9M | |
| Market Cap | $215M | $42M | $21M | · | · | · | · | · | · | $4.05B | · | |
| P/E | -4.5 | -0.5 | -0.7 | -0.5 | · | · | · | · | · | · | · | |
| P/S | 53.1 | 22.1 | 13.7 | · | · | · | · | · | · | · | · | |
| P/B | -6.8 | -3.4 | 1.0 | · | · | · | · | · | · | 410.9 | · | |
| P / Tangible Book | · | · | · | · | · | 355.7 | · | · | · | · | · | |
| P / Cash Flow | -9.7 | -2.0 | -0.9 | · | · | · | · | · | · | -538.7 | · | |
| P / FCF | -8.5 | -2.0 | -0.9 | · | · | · | · | · | · | -531.2 | · | |
| Earnings Yield | -22.0% | -195.8% | -150.0% | -206.4% | · | · | · | · | · | · | · |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $239.0K | $32.0K | $1M | $260.0K | $518.0K | $2M | $1M | $115.0K | $104.0K | $176.0K | $314.0K | $429.0K | $463.0K | $297.0K | $274.0K | $67.0K | |
| Cost of Revenue | $82.0K | $17.0K | $655.0K | $121.0K | $180.0K | $813.0K | $869.0K | $43.0K | $32.0K | $109.0K | $409.0K | $159.0K | $169.0K | $265.0K | $278.0K | $314.0K | |
| Gross Profit | $157.0K | $15.0K | $484.0K | $139.0K | $338.0K | $1M | $595.0K | $50.0K | $50.0K | $45.0K | $-117.0K | $248.0K | $272.0K | $10.0K | $-27.0K | $-269.0K | |
| R&D Expense | $4M | $5M | $6M | $4M | $3M | $3M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | |
| SG&A Expense | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $2M | $4M | $3M | $5M | $6M | |
| Operating Expenses | $12M | $4M | $24M | $11M | $10M | $8M | $34M | $14M | $5M | $9M | $16M | $7M | $9M | $-6M | $12M | $1M | |
| Operating Income | $-11M | $-4M | $-23M | $-11M | $-10M | $-7M | $-34M | $-14M | $-5M | $-9M | $-16M | $-7M | $-8M | $6M | $-12M | $-2M | |
| Other Non-op | $162.0K | $146.0K | $506.0K | $223.0K | $125.0K | $157.0K | $146.0K | $53.0K | $110.0K | $153.0K | $269.0K | $127.0K | $-1.0K | $-1.0K | $-365.0K | $62.0K | |
| Pretax Income | · | · | · | · | · | · | · | $-13M | $-5M | $-9M | $-16M | $-6M | $-8M | $6M | $-12M | $-2M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-11M | $-4M | $-23M | $-11M | $-10M | $-7M | $-34M | $-13M | $-5M | $-9M | $-16M | $-6M | $-8M | $3M | $-45M | $-9M | |
| EPS (Basic) | $-0.31 | $-0.12 | $-0.75 | $-0.34 | $-0.30 | $-0.26 | $-2.19 | $-0.98 | $-0.36 | $-1.13 | $-2.27 | $-0.81 | $-1.07 | $0.40 | $-10.04 | $-1.62 | |
| EPS (Diluted) | $-0.31 | $-0.12 | $-0.75 | $-0.34 | $-0.30 | $-0.26 | $-2.19 | $-0.98 | $-0.36 | $-1.13 | $-2.27 | $-0.81 | $-1.07 | $0.40 | $-10.04 | $-1.62 | |
| Shares (Basic) | 36,750,000 | 34,519,000 | · | 32,033,000 | 32,023,000 | 25,694,000 | · | 13,714,000 | 12,870,000 | 8,264,000 | · | 8,256,000 | 8,090,000 | 5,958,000 | · | 5,931 | |
| Shares (Diluted) | 36,750,000 | 34,519,000 | · | 32,033,000 | 32,023,000 | 25,694,000 | · | 13,714,000 | 12,870,000 | 8,264,000 | · | 8,256,000 | 8,090,000 | 5,963,000 | · | 5,931 | |
| EBITDA | $-11M | $-4M | · | $-10M | $-9M | $-6M | · | $-14M | $-5M | $-9M | · | $-7M | $-8M | $6M | · | $-9M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $28M | $12M | $19M | $24M | $31M | $9M | $3M | $9M | $6M | $9M | $14M | $17M | $12M | $20M | $32M | |
| Receivables | $192.0K | $157.0K | $1M | $258.0K | $512.0K | $4M | $2M | $209.0K | $85.0K | $161.0K | $484.0K | $2M | $2M | $2M | $2M | $2M | |
| Inventory | $207.0K | $382.0K | $446.0K | $471.0K | $693.0K | $459.0K | $410.0K | $232.0K | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $2M | $1M | $1M | $1M | $1M | $1M | $821.0K | $627.0K | $595.0K | $735.0K | $643.0K | $672.0K | $1M | $970.0K | $977.0K | $2M | |
| Current Assets | $21M | $31M | $15M | $21M | $27M | $36M | $12M | $5M | $10M | $7M | $11M | $17M | $21M | $16M | $26M | $37M | |
| PP&E (Net) | $6M | $9M | $9M | $6M | $6M | $7M | $6M | $6M | $6M | $5M | $5M | $5M | $7M | $8M | $9M | $9M | |
| Accum. Depreciation | $8M | $10M | $10M | $9M | $8M | $7M | $8M | $7M | $7M | $6M | $6M | $6M | $5M | $5M | $4M | $4M | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $19M | |
| Intangibles | · | · | $0 | $15M | $15M | $15M | $15M | $57M | $57M | $57M | $57M | $57M | $57M | $57M | $62M | $88M | |
| Other Non-current Assets | $556.0K | $574.0K | $593.0K | $672.0K | $702.0K | $642.0K | $691.0K | $699.0K | $563.0K | $438.0K | $463.0K | $520.0K | $329.0K | $367.0K | $371.0K | $366.0K | |
| Total Assets | $29M | $40M | $26M | $44M | $51M | $60M | $35M | $70M | $75M | $71M | $75M | $82M | $88M | $83M | $100M | $157M | |
| Accounts Payable | $2M | $2M | $3M | $1M | $1M | $2M | $2M | $872.0K | $1M | $908.0K | $953.0K | $1M | $875.0K | $1M | $1M | $2M | |
| Accrued Liabilities | $2M | $3M | $2M | $2M | $1M | $3M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $4M | |
| Current Liabilities | $10M | $12M | $12M | $8M | $7M | $10M | $7M | $9M | $7M | $8M | $7M | $8M | $8M | $9M | $12M | $13M | |
| Total Liabilities | $51M | $51M | $57M | $53M | $49M | $50M | $47M | $61M | $52M | $54M | $49M | $39M | $39M | $39M | $60M | $75M | |
| Common Stock | $395M | $394M | $369M | $369M | $368M | $367M | $338M | $327M | $326M | $311M | $310M | $310M | $310M | $296M | $295M | $293M | |
| Retained Earnings | $-416M | $-405M | $-401M | $-378M | $-367M | $-357M | $-351M | $-317M | $-304M | $-299M | $-290M | $-272M | $-266M | $-258M | $-261M | $-216M | |
| AOCI | $67.0K | $71.0K | $86.0K | $86.0K | $85.0K | $41.0K | $21.0K | $57.0K | $37.0K | $40.0K | $49.0K | $32.0K | $41.0K | $43.0K | $39.0K | $19.0K | |
| Stockholders' Equity | $-21M | $-11M | $-31M | $-9M | $1M | $10M | $-12M | $10M | $23M | $12M | $20M | $38M | $44M | $38M | $34M | $77M | |
| Liabilities + Equity | $29M | $40M | $26M | $44M | $51M | $60M | $35M | $70M | $75M | $71M | $75M | $82M | $88M | $83M | $100M | $157M | |
| Shares Outstanding | 32,623,000 | 32,286,000 | 28,683,000 | 28,625,000 | 28,617,000 | 28,599,000 | 17,453,000 | 13,374,000 | 13,368,000 | 8,273,000 | 8,261,000 | 8,261,000 | 8,241,000 | 119,279,000 | 5,932,000 | 118,619,000 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $665.0K | $631.0K | $563.0K | $584.0K | $559.0K | $491.0K | $563.0K | $340.0K | $326.0K | $335.0K | $303.0K | $404.0K | $435.0K | $450.0K | $466.0K | $391.0K | |
| Stock-based Comp | $661.0K | $615.0K | $721.0K | $521.0K | $504.0K | $473.0K | $499.0K | $450.0K | $386.0K | $418.0K | $484.0K | $608.0K | $834.0K | $834.0K | $3M | $3M | |
| Amort. of Intangibles | $0 | $0 | $0 | $0 | $0 | $7.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $812.0K | $976.0K | |
| Other Non-cash | · | $-5M | · | · | · | $-151.0K | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-8M | $-6M | $-5M | $-6M | $-6M | $-5M | $-6M | $-6M | $-4M | $-4M | $-2M | $-5M | $-8M | $-10M | $-11M | |
| CapEx | $779.0K | $613.0K | $1M | $1M | $349.0K | $307.0K | $214.0K | $87.0K | $191.0K | $24.0K | $264.0K | · | · | · | $802.0K | $859.0K | |
| Investing Cash Flow | $-779.0K | $-613.0K | $-1M | $-1M | $-349.0K | $-307.0K | $-210.0K | $-87.0K | $-191.0K | $-24.0K | $103.0K | $-1M | $123.0K | $-1M | $-802.0K | $-859.0K | |
| Stock Issued | $0 | $26M | $0 | $0 | $0 | $29M | $10M | $0 | $16M | $0 | $0 | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | $26M | · | · | · | $29M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-564.0K | $25M | $-252.0K | $-120.0K | $-114.0K | $29M | $11M | $-255.0K | $10M | $0 | $-30.0K | $-30.0K | $12M | $-28.0K | $-100.0K | $-572.0K | |
| Net Change in Cash | $-11M | $16M | $-7M | $-6M | $-7M | $22M | $5M | $-6M | $4M | $-4M | $-4M | $-4M | $6M | $-10M | $-11M | $-13M | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Free Cash Flow | · | $-8M | · | · | · | $-6M | · | · | · | $-4M | · | · | · | · | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.7% | 46.9% | · | 53.5% | 67.6% | 62.0% | · | 43.5% | 48.1% | -55.7% | · | 57.8% | 58.8% | 3.4% | · | -115.4% | |
| Operating Margin | -4770.7% | -13790.6% | · | -4249.2% | -1900.0% | -318.0% | · | -11752.2% | -4453.9% | -5265.3% | · | -1518.2% | -1791.4% | 1952.2% | · | -906.7% | |
| Net Margin | -4711.3% | -13406.2% | · | -4174.6% | -1880.7% | -312.0% | · | -11733.0% | -4355.8% | -5186.9% | · | -1512.6% | -1799.8% | 1021.2% | · | -917.7% | |
| Pretax Margin | · | · | · | · | · | · | · | -11733.0% | -4355.8% | -5186.9% | · | -1512.6% | -1799.8% | 2006.4% | · | -917.7% | |
| EBITDA Margin | -4492.5% | -11818.8% | · | -4024.6% | -1792.1% | -295.0% | · | -11752.2% | -4453.9% | -5265.3% | · | -1518.2% | -1791.4% | 1952.2% | · | -906.7% | |
| ROA | -28.2% | -8.5% | · | -19.0% | -15.6% | -10.2% | · | -17.8% | -5.6% | -11.9% | · | -5.4% | -6.4% | 2.6% | · | -5.7% | |
| ROE | 111.5% | 1814.0% | · | -4215.1% | -81.9% | -61.2% | · | -57.1% | -13.7% | -36.9% | · | -11.3% | -13.1% | 6.4% | · | -10.6% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.5 | · | 2.8 | 4.0 | 3.7 | · | 0.5 | 1.4 | 0.8 | · | 2.1 | 2.7 | 1.7 | · | 2.8 | |
| Quick Ratio | 1.7 | 2.4 | · | 2.5 | 3.7 | 3.6 | · | 0.4 | 1.3 | 0.7 | · | 2.0 | 2.5 | 1.5 | · | 2.6 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.2 | 0.0 | · | 0.3 | 0.5 | 3.5 | · | 0.4 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 0.7 | 0.0 | · | 1.1 | 1.7 | 1.2 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.3 | 0.1 | · | 0.7 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.65 | $-0.33 | · | $-0.32 | $0.04 | $0.36 | · | $0.73 | $1.70 | $1.40 | · | $4.55 | $5.29 | $0.32 | · | $0.65 | |
| Revenue / Share | $0.01 | $0.00 | · | $0.01 | $0.02 | $0.08 | · | $0.01 | $0.01 | $0.02 | · | $51.96 | $57.23 | $0.00 | · | · | |
| Cash Flow / Share | · | $-0.22 | · | · | · | $-0.23 | · | · | · | $-0.46 | · | · | · | $-0.08 | · | · | |
| Cash / Share | $0.54 | $0.87 | · | $0.65 | $0.85 | $1.08 | · | $0.25 | $0.69 | $0.67 | · | $1.67 | $2.11 | $0.10 | · | $0.27 | |
| EPS (TTM) | $-1.52 | $-1.51 | · | $-3.09 | $-3.73 | $-3.79 | · | $-4.74 | $-4.57 | $-5.28 | · | $-11.52 | $-12.33 | $-12.74 | · | · |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | · | $4M | $4M | $4M | · | $709.0K | $1M | $1M | · | $1M | $1M | $875.0K | · | $-1M | |
| Net Income TTM | $-49M | $-48M | · | $-61M | $-63M | $-58M | · | $-43M | $-36M | $-40M | · | $-57M | $-60M | $-60M | · | $-64M | |
| Market Cap | $192M | $106M | · | $95M | $86M | $88M | · | $38M | $39M | $24M | · | $26M | $38M | $844M | · | $1.73B | |
| P/E | -3.9 | -2.2 | · | -1.1 | -0.8 | -0.8 | · | -0.6 | -0.6 | -0.6 | · | -0.3 | -0.4 | -0.6 | · | · | |
| P/S | 115.3 | 54.3 | · | 21.6 | 20.3 | 22.8 | · | 53.8 | 38.5 | 17.5 | · | 17.6 | 34.4 | 965.1 | · | -1378.9 | |
| P/B | -9.0 | -9.9 | · | -10.3 | 78.7 | 8.6 | · | 3.9 | 1.7 | 2.1 | · | 0.7 | 0.9 | 22.3 | · | 22.5 | |
| P / Cash Flow | · | -13.9 | · | · | · | -14.9 | · | · | · | -6.3 | · | · | · | -87.3 | · | · | |
| Earnings Yield | -25.8% | -46.0% | · | -93.1% | -123.5% | -123.9% | · | -166.3% | -154.9% | -180.2% | · | -369.2% | -268.0% | -179.9% | · | · |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $4M | $2M | $2M | $958.0K | $2M |
| Margem Bruta % | 56.7% | 39.3% | 27.5% | · | · |
| Margem Operacional % | -1260.8% | -3245.1% | -1672.4% | · | · |
| Lucro líquido | $-50M | $-61M | $-28M | $-73M | $-64M |
| EPS Diluído | $-1.65 | $-4.66 | $-3.75 | $-13.25 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 1.3 | 1.6 | 1.5 | · | · |
| Índice de Liquidez Seca | 1.1 | 1.4 | 1.4 | · | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-25M | $-21M | $-24M | · | · |
Investidores institucionais (13F) 43 declarantes · $111.8M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Detentores
43
Valor detido
$111.8M
Novas posições
11
Posições encerradas
13
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 11 (-6 vs trimestre anterior) | 13 (+6 vs trimestre anterior) | 10 (-1 vs trimestre anterior) | 8 (+2 vs trimestre anterior) | -474K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| BROADWOOD CAPITAL INC | $74.840.816 | 12.684.884 | 66,93% | Ações |
| AWM Investment Company, Inc. | $16.736.483 | 2.836.692 | 14,97% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.341.497 | 735.847 | 3,88% | Ações |
| VANGUARD GROUP INC | $3.950.064 | 526.675 | 3,53% | Ações |
| PURA VIDA INVESTMENTS, LLC | $2.860.585 | 484.845 | 2,56% | Ações |
| Family Office Research LLC | $2.176.207 | 368.849 | 1,95% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $1.516.953 | 256.903 | 1,36% | Ações |
| JANE STREET GROUP, LLC | $930.324 | 157.682 | 0,83% | Ações |
| BlackRock, Inc. | $888.074 | 150.521 | 0,79% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $734.998 | 124.576 | 0,66% | Ações |
| STATE STREET CORP | $543.532 | 92.124 | 0,49% | Ações |
| MILLENNIUM MANAGEMENT LLC | $486.744 | 82.499 | 0,44% | Ações |
| UBS Group AG | $314.329 | 53.276 | 0,28% | Ações |
| NORTHERN TRUST CORP | $289.631 | 49.090 | 0,26% | Ações |
| OSAIC HOLDINGS, INC. | $230.901 | 39.136 | 0,21% | Ações |
| MORGAN STANLEY | $209.539 | 35.515 | 0,19% | Ações |
| Jefferies Financial Group Inc. | $106.790 | 18.100 | 0,10% | Ações |
| MARSHALL WACE, LLP | $97.922 | 16.597 | 0,09% | Ações |
| ExodusPoint Capital Management, LP | $82.771 | 14.029 | 0,07% | Ações |
| AXQ CAPITAL, LP | $79.101 | 13.407 | 0,07% | Ações |
| Flatrock Wealth Partners LLC | $76.960 | 13.044 | 0,07% | Ações |
| TWO SIGMA INVESTMENTS, LP | $65.496 | 11.101 | 0,06% | Ações |
| XTX Topco Ltd | $63.384 | 10.743 | 0,06% | Ações |
| Private Advisor Group, LLC | $61.454 | 10.416 | 0,05% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $34.226 | 5.801 | 0,03% | Ações |
| Vanguard Global Advisers, LLC | $34.073 | 5.775 | 0,03% | Ações |
| EverSource Wealth Advisors, LLC | $29.500 | 5.000 | 0,03% | Ações |
| Tower Research Capital LLC (TRC) | $15.877 | 2.691 | 0,01% | Ações |
| Steward Partners Investment Advisory, LLC | $11.564 | 1.960 | 0,01% | Ações |
| ORG Partners LLC | $3.375 | 450 | 0,00% | Ações |
| SBI Securities Co., Ltd. | $1.092 | 185 | 0,00% | Ações |
| FNY Investment Advisers, LLC | $1.077 | 182.561 | 0,00% | Ações |
| ROYAL BANK OF CANADA | $1.000 | 251 | 0,00% | Ações |
| JPMORGAN CHASE & CO | $835 | 154 | 0,00% | Ações |
| JONES FINANCIAL COMPANIES LLLP | $340 | 63 | 0,00% | Ações |
| Caitong International Asset Management Co., Ltd | $266 | 45 | 0,00% | Ações |
| Piscataqua Savings Bank | $147 | 25 | 0,00% | Ações |
| ALBION FINANCIAL GROUP /UT | $42 | 7 | 0,00% | Ações |
| WELLS FARGO & COMPANY/MN | $41 | 7 | 0,00% | Ações |
| Cassaday & Co Wealth Management LLC | $36 | 6 | 0,00% | Ações |
| Global Retirement Partners, LLC | $6 | 1 | 0,00% | Ações |
| Farther Finance Advisors, LLC | $6 | 1 | 0,00% | Ações |
| Motiv8 Investments LLC | $0 | 10 | 0,00% | Ações |
Ativistas e proprietários de 5%+ 5 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Broadwood Partners, L.P., Broadwood Capital, Inc., Neal C. Bradsher ×15 declarações | 27 de Abril de 2026 | 39,70% | Emenda | Investimento passivo | SEC |
| Lineage Cell Therapeutics, Inc. 1 S.S. OR ×4 declarações | 8 de Janeiro de 2021 | · | Declaração inicial | · | SEC |
| BioTime, Inc. 1 S.S. OR ×5 declarações | 5 de Julho de 2019 | · | Declaração inicial | · | SEC |
| BioTime, Inc. S.S. OR | 29 de Agosto de 2016 | · | Declaração inicial | Campanha no conselho | SEC |
| BioTime, Inc. | 31 de Dezembro de 2015 | · | Declaração inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 29 insiders · 16 diretores · 13 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Josh Riggs | CEO and President | 26 de Março de 2026 M | 38.365 | 0 | 0 | $0 |
| Ronald Asbury Andrews | Former CEO | 7 de Dezembro de 2022 A | 583.212 | 0 | 0 | $0 |
| William Annett | President and CEO | 14 de Março de 2019 A | 3.500 | 0 | 0 | $0 |
| Andrea S. James | Chief Financial Officer | 26 de Março de 2026 M | 206.060 | 0 | 0 | $0 |
| Anish M. John | Chief Financial Officer | 24 de Fevereiro de 2023 A | 150.000 | 0 | 0 | $0 |
| Mitchell S Levine | Chief Financial Officer | 15 de Março de 2022 A | 87.080 | 0 | 0 | $0 |
| Gisela Paulsen | Former President and COO | 16 de Dezembro de 2022 D | 366.500 | 0 | 0 | $0 |
| Albert P Parker | COO | 11 de Dezembro de 2020 A | 10.586 | 0 | 0 | $0 |
| James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | 26 de Março de 2026 M | 3.711 | 0 | 0 | $0 |
| Douglas T. Ross | Former CSO | 21 de Dezembro de 2022 A | 234.114 | 0 | 0 | $0 |
| Li Yu | VP Cntrllr/Prncpl Acctng Offcr | 18 de Maio de 2022 M | 16.872 | 0 | 0 | $0 |
| Padma Sundar | Chief Commercial Officer | 15 de Março de 2022 A | 4.177 | 0 | 0 | $0 |
| Lyndal K. Hesterberg | CSO | 11 de Dezembro de 2020 A | 7.477 | 0 | 0 | $0 |
| Tony T Kalajian | Sr.VP/Chief Accounting Officer | 3 de Agosto de 2020 P | 15.000 | 0 | 0 | $0 |
| Kristine C. Mechem | VP of Marketing | 7 de Junho de 2018 A | · | 0 | 0 | $0 |
| Karen B. Chapman | Vice President of Research | 16 de Fevereiro de 2016 A | · | 0 | 0 | $0 |
| Andrew J. Last | Conselheiro | 1 de Julho de 2026 F | 58.752 | 0 | 0 | $0 |
| Andrew Arno | Conselheiro | 1 de Julho de 2026 F | 156.785 | 0 | 0 | $0 |
| Lou Silverman | Conselheiro | 1 de Julho de 2026 F | 55.807 | 0 | 0 | $0 |
| Alfred D Kingsley | Conselheiro | 23 de Junho de 2023 A | 489.111 | 0 | 0 | $0 |
| Jennifer L. Carter | Conselheiro | 15 de Agosto de 2022 A | 30.500 | 0 | 0 | $0 |
| Melinda Griffith | Conselheiro | 15 de Agosto de 2022 A | 30.000 | 0 | 0 | $0 |
| Cavan M. Redmond | Conselheiro | 24 de Junho de 2022 M | 120.863 | 0 | 0 | $0 |
| Aditya P. Mohanty | Conselheiro | 17 de Julho de 2019 A | · | 0 | 0 | $0 |
| Don M Bailey | Conselheiro | 15 de Junho de 2017 A | · | 0 | 0 | $0 |
| Michael D West | Conselheiro | 16 de Fevereiro de 2016 A | · | 0 | 0 | $0 |
| Patrick W Smith | Detentor de 10% | 7 de Fevereiro de 2025 J | 3.258.485 | 0 | 0 | $0 |
| John Peter Gutfreund | · | 30 de Junho de 2023 J | 0 | 0 | 0 | $0 |
| BIOTIME INC | · | 2 de Janeiro de 2020 S | 6.041.154 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 3 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
IMDX Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 11 analistas
COMPRA
Alvo mediano
$8.50
+147,1%
2 18,2%
Compra forte
6 54,5%
Compra
3 27,3%
Manter
0 0,0%
Venda
0 0,0%
Venda forte
Preço-alvo de 12 meses
4 analistas · 2026-09-29Alvo médio $8.25 +139,8%
← Abaixo de todos os alvos
Preço atual $3.44
Mín$4.00
Média$8.25
Máx$12.00
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| IMDX | $215M | -4.5 | 115.6% | -1238.5% | 330.8% | 56.7% |
| INO | $120M | -1.0 | -70.0% | -130000.0% | -322.8% | · |
| HURA | · | -1.2 | · | · | · | · |
| VTVT | · | · | · | · | -70.4% | · |
| CRBP | $143M | -1.4 | · | · | -60.8% | · |
| UNCY | $128M | -3.5 | -29.0% | · | -113.9% | · |
| GNLX | $166M | -5.1 | 0.00% | -401812.5% | -181.4% | · |
| COYA | $121M | -4.6 | 123.6% | -267.1% | -59.5% | · |
| XGN | $139M | -6.5 | 19.7% | -30.0% | -103.7% | 58.3% |
| BDTX | $139M | 6.2 | · | 31.9% | 18.3% | · |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Ago 10, 2026